Status:
COMPLETED
Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C
Lead Sponsor:
Indiana University School of Medicine
Conditions:
Glaucoma
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
A clinical trial to establish the long term response of using intraoperative 5-fluorouracil (5-FU) versus mitomycin C (MMC) in trabeculectomy glaucoma surgery. Antiproliferative agents such as 5-fluor...
Detailed Description
Glaucoma is a life-long progressive disease, and patients are living longer. Therefore, a long term full evaluation of the efficacy of intraoperative 5-FU and MMC needs to be performed to assess the t...
Eligibility Criteria
Inclusion
- Only patients deemed successful as 36 months will be included. These patients will have participated in the randomized prospective study trial comparing intraoperative 5-FU and mitomycin C in primary trabeculectomy.
Exclusion
- Only patients deemed successful as 36 months will be included. These patients will have participated in the randomized prospective study trial comparing intraoperative 5-FU and mitomycin C in primary trabeculectomy.
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
End Date :
August 1 2007
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00346489
Start Date
September 1 2004
End Date
August 1 2007
Last Update
December 27 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital and Outpatient Center
Indianapolis, Indiana, United States, 46202
2
IU Eye at Carmel
Indianapolis, Indiana, United States, 46290